A Global Active Surveillance for Community Acquired Pneumonia
NCT ID: NCT00929721
Last Updated: 2012-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5172 participants
INTERVENTIONAL
2009-12-31
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases.
NCT04944719
Description of Pneumococcal Pneumonia
NCT03322670
Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia
NCT05903352
Community-Acquired Pneumonia (CAP) Surveillance
NCT01416506
Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia
NCT01086397
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects with Community-Acquired Pneumonia
Subjects with Community-Acquired Pneumonia
Blood draw
culture for Streptococcus pneumoniae Frequency-1
Chest X-ray
image of the lungs to assess changes consistent with pneumonia Frequency-1
urine specimen
assay for the presence of Streptococcus pneumoniae Binax and UAD
Nasopharyngeal swab
culture for Streptococcus pneumoniae Frequency-1
sputum
culture for Streptococcus pneumoniae Frequency-1
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood draw
culture for Streptococcus pneumoniae Frequency-1
Chest X-ray
image of the lungs to assess changes consistent with pneumonia Frequency-1
urine specimen
assay for the presence of Streptococcus pneumoniae Binax and UAD
Nasopharyngeal swab
culture for Streptococcus pneumoniae Frequency-1
sputum
culture for Streptococcus pneumoniae Frequency-1
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject must reside in the surveillance area
* Subjects who present to a study healthcare facility where the treating physician clinically suspects CAP
Exclusion Criteria
* Hospital Acquired pneumonia (ie, develops signs and symptoms of pneumonia after being hospitalized for 48 hours or more).
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Chrzanów, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6115A1-4000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.